Efficacy of Korean Manupuncture on Pain in Women With Endometriosis: a Parallel-group Randomized Controlled Trial
ENVOL
1 other identifier
interventional
74
1 country
1
Brief Summary
Endometriosis is defined as the presence and development of hormone-dependent endometrial tissue comprising both glands and stroma outside the endometrium and myometrium. It affects 10-15% of women of childbearing age; of these, 25% are diagnosed following a consultation for infertility, and 25% following a consultation for pelvic pain. This disease has a strong functional (pain and infertility) and organic impact, its numerous symptoms can have a considerable effect on quality of life. Individualized analgesic management with multidisciplinary care (medical, surgical and psychological) can improve quality of life for women with endometriosis, but current treatment remains insufficient. Korean manupuncture is a complementary treatment technique that does not interact with current treatments. It's a holistic discipline that draws up a highly detailed map of the body's correspondence on the hand. Each body zone corresponds to a zone on the hand. The aim of this research is to evaluate the effect of Korean manupuncture on endometriosis-related pain. Patients will be randomly assigned to 2 groups, 30 to the "Korean manupuncture" group and 30 to the "placebo/control" group. Patients will be blinded to their assigned group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedStudy Start
First participant enrolled
November 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 9, 2025
CompletedFebruary 9, 2026
February 1, 2026
1.6 years
September 29, 2023
February 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Variation in the Visual Analog Scale (VAS)
Between Day 1 and Day 29
Study Arms (2)
Korean manupuncture
EXPERIMENTALPlacebo/control
PLACEBO COMPARATORInterventions
Energy assessment on hands and body Correspondence point technique on hands Energy rebalancing with ki Maeks on hands Moxa technique on hands
Energy assessment on hands and body Correspondence point technique on the hands Energy rebalancing with ki Maeks on hands (use of Qi bong) Moxa technique on hands (placebo moxas)
Eligibility Criteria
You may qualify if:
- Person having given oral consent
- Woman of legal age
- Woman diagnosed with endometriosis consulting for pain management
You may not qualify if:
- Not affiliated to the national health insurance system
- Person under legal protection (curatorship, guardianship)
- Person under court order
- Pregnant or breast-feeding women
- Menopausal women (menopause is defined as amenorrhea lasting more than 12 consecutive months)
- An adult unable to give consent
- Women who have had a hysterectomy
- Women who cannot speak or read French
- Hands not accessible for treatment
- Inability to follow the entire protocol
- Cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Dijon Bourgogne
Dijon, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2023
First Posted
October 10, 2023
Study Start
November 29, 2023
Primary Completion
July 9, 2025
Study Completion
July 9, 2025
Last Updated
February 9, 2026
Record last verified: 2026-02